The Effect of 5-hydroxytryptophan on ADHD Traits and Eye Movements

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity of Sheffield

About this trial

The aim of this project is to look at the impact of 5-Hydroxytryptophan (5-HTP) on distractibility. 5-HTP is the precursor to the neurotransmitter serotonin and is a chemical that the body produces naturally. There is evidence that distractibility is associated with a decreased level of serotonin. This research aims to see if giving people 5-HTP will alter their distractibility, which will form part of an initial assessment as to whether 5-HTP could be used to support people with attention problems. The study involves completing a short survey about mental health and behaviours, and if eligible, participation in an in-person study at the University of Sheffield. The in-person session involves completing some cognitive tasks to look at eye movement, taking 5-HTP or a sugar tablet with no active ingredients, and then completing the tasks again after a 90-minute wait.

Eligibility criteria

Qualifiers

18-65 years of age

Normal or corrected to normal vision with contact lenses.

Score of <9 or >14 on the ASRS v5 (assessed in pre screen questionnaire)

Disqualifiers

Current use of psychostimulant medication or medication for the treatment of ADHD

Current use of medications known to impact the serotonergic system (e.g., SSRIs).

Smoking or vaping

Pregnancy

Trial design

Treatments tested in this trial

  • 5-hydroxytryptophan (food supplement) 200mg
  • 5-hydroxytryptophan (food supplement) 300mg
  • Placebo

Treatment groups

150 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Sponsors and collaborators